Assessment of Quality of Life in Patients with Dermatological Conditions in Primary Healthcare in Goa, India

    October 2019 in “ International journal of contemporary medical research ”
    S Arulprakash, Delia Basil D'souza
    Image of study
    TLDR Skin diseases have a small to moderate impact on the quality of life of patients in Goa, India.
    The study conducted at an Urban Health Centre in Goa, India, involved 150 adult patients with skin ailments and used the Dermatology Life Quality Index (DLQI) to assess their quality of life (QoL). The results indicated a small to moderate effect of skin diseases on QoL, with a mean DLQI score of 6.67 ± 4.147. Younger patients and males were more affected, with males having higher mean DLQI scores. The study highlighted the need for better management of skin diseases in primary healthcare, including special training for healthcare professionals and the addition of essential medications to the inventory. It also suggested using DLQI as a routine tool for primary healthcare decisions. Of the 48 patients referred to tertiary care, 47.9% reported a large effect on their life, but 93.8% had no change in diagnosis, although they received different medications. The study recommends caution in interpreting the results due to the small sample size and suggests a larger, multicentric study for more robust data. The study was approved by the Institutional Ethics Committee, Goa Medical College, Goa.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 196 results

      community DHT Harms Scalp Microbiome: DHT Itch is REAL

      in Research/Science  406 upvotes 5 days ago
      Increased Malassezia and Cutibacterium in the scalp microbiome are linked to higher sebum production and inflammation in androgenetic alopecia (AGA). Treatments include ciclopirox shampoo, benzoyl peroxide shampoo, clobetasol propionate, calcipotriol, minoxidil, finasteride, and dutasteride.

      community Binding affinity of pyrilutamide!

      in Update  168 upvotes 2 years ago
      Pyrilutamide, a nonsteroidal antiandrogen drug under development for the potential treatment of androgenic alopecia. The conversation discusses its binding affinity to the androgen receptor and the timeline for possible availability after trials are completed in the United States and China.

      community If RU58841 is such an effective anti androgen

      in Research/Science  46 upvotes 1 year ago
      RU58841 is discussed as a topical anti-androgen for hair loss, but its effectiveness and safety are not well-documented, leading to mixed opinions and experiences among users. Some combine it with finasteride, but concerns about side effects and lack of FDA approval limit its popularity.

      community Trying to understand finasteride side effects and post finasteride syndrome

      in Finasteride/Dutasteride  71 upvotes 4 years ago
      The conversation discusses the side effects of finasteride, including low libido and erectile dysfunction, and the possibility of these effects being permanent, known as post-finasteride syndrome (PFS). Some users report personal experiences with PFS and debate whether the condition is real, with varying opinions on the reversibility of side effects and the role of individual biology.

      community I’ve read multiple times that Fin increases hair quality… NOT for me!

      in Treatment  97 upvotes 1 year ago
      A user has been on finasteride for 6 months and feels their hair quality has worsened, experiencing more hair loss and scalp irritation. They are considering seeing a dermatologist, while others suggest the issue might be unrelated to finasteride, possibly due to deficiencies or other conditions.

    Similar Research

    5 / 1000+ results